Earlier treatment and higher CD4 counts linked to smaller HIV reservoir
Twice-a-year injected drug shows promise for first-line HIV treatment
Spanish studies highlight scale of late presentation and its consequences for treatment
Same-day ART initiation linked to increased risk of negative outcomes
Alendronate can prevent bone loss in people starting HIV treatment
People with NNRTI resistance have poorer responses to dolutegravir, South African study finds
More weight gain in people starting HIV treatment with newer integrase inhibitors or darunavir
HIV programmes in Africa need new models of care for people’s first six months on treatment
No increased risk of diabetes with integrase inhibitors in people starting HIV treatment
